2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theVenous Thromboembolism Market?

The anticipated growth of the venous thromboembolism market is largely reliant on the expansion of the healthcare infrastructure. The healthcare sector essentially consists of various economic system divisions dedicated to providing products and services aimed at curing diseases, preventing ill health, rehabilitating patients, and offering palliative care. The growth of the healthcare sector substantially facilitates the enlargement of Institutional structure, guidelines, practices and learning programs imperative for supporting the implementation of VTE prevention measures. For instance, the American Health Care Association, a nonprofit organization based in the US, reported an increase in the number of hospitals in the US from 6,093 in 2022 to 6,129 in May 2023. Additionally, the UK’s Office for National Statistics stated that the healthcare spending in the UK in 2023 was approximately £292 billion, marking a nominal rise of 5.6%. They also noted that the expenditure on long-term health and social care grew by 2.8% in real terms in 2022. Such an expansion of the healthcare sector consequently fuels the growth of the venous thromboembolism market. An increase in the number of orthopedic procedures is another factor pushing the growth of the venous thromboembolism market. Orthopedic procedures are essentially surgeries conducted to rectify conditions related to the spine and joints and to correct skeletal deformities. Procedures like total knee arthroplasty (TKA), total hip arthroplasty (THA), and hip fracture surgery (HFS) have been linked with a high risk of VTE, leading to increased adoption of compression devices for DVT prophylaxis. These devices are intended to prevent the formation of blood clots in the deep veins of the legs, potentially causing venous thromboembolism (VTE). Research published by the National Library of Medicine, a US biomedical library, in February 2023 suggested an expected rise of THA and TKA procedures by 719,364 and 1,222,988 respectively by the year 2040. Projections for TKAs total at 2,917,959 by 2060, whereas the THA total is expected to reach 1,982,099 by the same year. This surge in orthopedic procedures effectively drives the expansion of the venous thromboembolism market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp

#How Does the ProjectedVenous Thromboembolism Market Growth Compare Over the Forecast Period?

The market for venous thromboembolism has seen an incremental expansion over the past few years. It is slated to increase from $2.44 billion in 2024 to $2.55 billion in 2025, marking a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this increase during the historic period include an aging society, breakthroughs in anticoagulants, progressive reimbursement policies, and surges in investments.

The market for venous thromboembolism is projected to steadily expand in the upcoming years. The market size is anticipated to reach $3.02 billion by 2029, with a compound annual growth rate (CAGR) of 4.4%. Various factors such as global healthcare access, assessment of genetic risk, telemedicine, remote monitoring, and patient education support contribute to the growth in this projected period. The forecast period will also see major trends like extended thromboprophylaxis, innovative oral anticoagulants, tailor-made treatment plans, and sophisticated diagnostic imaging.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13001

Which Upcoming Market Trends and Innovations Are Set to Influence theVenous Thromboembolism Market’s Path Forward?

Leading firms in the venous thromboembolism market are focusing on the creation of innovative anticoagulant medications and strategies to maintain their industry standing. The progress in anticoagulant technology could pave the way for the creation of more effective medicines that can prevent or treat venous thromboembolism. For instance, Anthos Therapeutics, an American company specializing in clinical-stage biotherapeutics, secured regulatory approval for its novel anticoagulant drug, abelacimab, from the U.S. Food and Drug Administration in September 2022. This new drug, a fully human monoclonal antibody, is proposed for the prevention of stroke and systemic embolism in people with atrial fibrillation. Abelacimab, a dual-action antibody developed recently for monthly usage, is designed to stimulate hemostasis-preserving anticoagulation by blocking Factor XI.

Who Are the Dominant Market Players Pushing the Boundaries of theVenous Thromboembolism Market?

Major companies operating in the venous thromboembolism market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Menarini Group, Ipsen S.A., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., LEO Pharma A/S, Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Glenmark Pharmaceuticals Ltd., Portola Pharmaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

What Are the Core Segments of the Venous Thromboembolism Market, and How Do They Contribute to Growth?

The venous thromboembolism market covered in this report is segmented –

1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types

2) By Treatment: Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Treatment

3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT

2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE

3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13001&type=smp

What Regions Are Dominating the Venous Thromboembolism Market Growth?

North America was the largest region in the venous thromboembolism market in 2024. The regions covered in venous thromboembolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Venous Thromboembolism Market 2025, By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: